Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.13. Hemispherx BioPharma shares last traded at $0.12, with a volume of 414,706 shares trading hands.
Hemispherx BioPharma Stock Performance
The firm has a 50 day moving average price of $0.15.
Hemispherx BioPharma Company Profile
Hemispherx Biopharma, Inc, a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).
Further Reading
- Five stocks we like better than Hemispherx BioPharma
- Upcoming IPO Stock Lockup Period, Explained
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Insider Buying Explained: What Investors Need to Know
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Hemispherx BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemispherx BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
